Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Posts
- Category: important (continued)
- Advances on many fronts in the battle against the protein that causes Huntington's disease
- Affrontare il rischio genetico e proteggere la speranza
- Amendment to the RG6042 Phase III GENERATION HD1 study design
- Animal study points to a treatment for Huntington's disease
- Annunciato trial clinico per la Malattia di Huntington: farmaco per l' abbassamento dei livelli di huntintina entra in Fase I di sperimentazione nel 2015
- Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease
- Auspex Pharmaceuticals Receives FDA Orphan Drug Designation of SD-809 for Treatment of Huntington's Disease
- BARCELLONA 19 - 21 SETTEMBRE: 8° MEETING PLENARIO DEL NETWORK EUROPEO PER LA MALATTIA DI HUNTINGTON – NOVITA’ E PROSPETTIVE
- Brain Degeneration In Huntington’s Disease Caused By Amino Acid Deficiency
- BRAIN Unit researchers break Huntington’s disease stigma
- Broken signals lead to neurodegeneration
- Cattaneo: «Basta abusare della speranza di chi soffre»
- Cell transplants may alleviate Huntington's disease
- Comunicato AICH - Roma Onlus
- Cure for Huntington’s disease within reach
- DATA NOW AVAILABLE
- Deutetrabenazine for Treatment of Chorea in Huntington Disease
- Discovery and Early Clinical Development of ISIS-HTTRx, the First HTT-Lowering Drug to Be Tested in Patients with Huntington’s Disease
- Discovery shows promise for treating Huntington's Disease
- Disease in a dish approach could aid Huntington's disease discovery
- EHDN NEWS
- EuroBuzz 2014: day one
- EuroBuzz 2014: day three
- EuroBuzz 2014: day two
- Existing Compound Holds Promise for Reducing Huntington’s Disease Progression
- Fatal cellular malfunction identified in Huntington’s disease
- FDA approves a new drug for symptoms of Huntington's disease
- FDA Approves Second Drug for Huntington Disease Symptom
- First Huntington's patients dosed with 'gene silencing' drug
- First Patient Enrolled in Pivotal Study of RG6042 (IONIS-HTT Rx) for People with Huntington's Disease
- Fresh Updates from First Huntingtin Lowering Study Publication
- Gene variants that modify Huntington’s disease symptom onset could lead to new therapeutic strategies
- Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial
- Genetic modifier for Huntington’s disease progression identified
- GLOBAL HUNTINGTON’S DISEASE PATIENT ADVOCACY ORGANIZATIONS UNITE TO FORM HUNTINGTON’S DISEASE COALITION FOR PATIENT ENGAGEMENT (HD-COPE)
- Harnessing the power of viruses to treat Huntington's disease
- HD InsightsA - H u n t i n g t o n d i s e a s e r e s e a r c h Issue No 12 -- Fall 2015 p e r i o d i c a l
- HD mice provide a useful failure
- How a Silly Putty ingredient could advance stem cell therapies
- How close are we to a cure for Huntington’s?
- How NOT to write a news article about a clinical trial
- Human skin cells reprogrammed directly into brain cells
- Huntingtina, le due facce di una proteina
- Huntington disease
- Huntington drug successfully lowers levels of disease-causing protein
- Huntington proteins and their nasty 'social network'
- Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
- Huntington's disease goes viral as UniQure inches ahead in gene therapy race
- Huntington's Disease Monkeys Display Progressive Clinical Changes and Neurodegeneration
- Huntington's disease protein controls movement of precious cargo inside cells, study finds
Plugin by dagondesign.com
